Expanded Access Program for Daraxonrasib launching soon. Eligible patient and physician referrals expected to begin next week.
News

Latest News and Insights in Healthcare

NHO Revive is dedicated to continuous innovation in oncology. Stay updated on advanced clinical trials, cutting-edge treatments, and expert opinions from our team. Dive into our in-depth articles on new research and gain valuable insights into the latest technologies transforming cancer care. Join us in advancing medical knowledge and improving patient outcomes through groundbreaking clinical trials.